-
公开(公告)号：US20240360227A1
公开(公告)日：2024-10-31
申请号：US18760539
申请日：2024-07-01
Applicant: Viridian Therapeutics, Inc.
Inventor： Vahe BEDIAN , Yang ZHAO
IPC: C07K16/28 , A61K31/7088 , A61K35/12 , A61P27/02 , C07K16/46
CPC classification number: C07K16/2863 , A61K31/7088 , A61K35/12 , A61P27/02 , C07K16/461 , C07K2317/51 , C07K2317/515 , C07K2317/52 , C07K2317/56 , C07K2317/622 , C07K2317/94
Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
-
公开(公告)号：US20240343814A1
公开(公告)日：2024-10-17
申请号：US18760575
申请日：2024-07-01
Applicant: Viridian Therapeutics, Inc.
Inventor： Vahe BEDIAN , Yang ZHAO
IPC: C07K16/28 , A61K31/7088 , A61K35/12 , A61P27/02 , C07K16/46
CPC classification number: C07K16/2863 , A61K31/7088 , A61K35/12 , A61P27/02 , C07K16/461 , C07K2317/51 , C07K2317/515 , C07K2317/52 , C07K2317/56 , C07K2317/622 , C07K2317/94
Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
-
公开(公告)号：US20230279122A1
公开(公告)日：2023-09-07
申请号：US18150514
申请日：2023-01-05
Applicant: Viridian Therapeutics, Inc.
Inventor： Vahe Bedian , Peter Harwin , Tomas Kiselak , Angela She , Jonathan Violin , Yang Zhao
CPC classification number: C07K16/2863 , A61P27/02 , A61K9/0019 , C07K2317/51 , C07K2317/515 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/94 , A61K2039/505
Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
-
公开(公告)号：US20220275096A1
公开(公告)日：2022-09-01
申请号：US17724639
申请日：2022-04-20
Applicant: Viridian Therapeutics, Inc.
Inventor： Vahe Bedian , Peter Harwin , Tomas Kiselak , Angela She , Jonathan Violin , Yang Zhao
Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
-
公开(公告)号：US20240043546A1
公开(公告)日：2024-02-08
申请号：US18364620
申请日：2023-08-03
Applicant: Viridian Therapeutics, Inc.
Inventor： Vahe Bedian , Peter Harwin , Tomas Kiselak , Angela She , Jonathan Violin , Yang Zhao
CPC classification number: C07K16/2863 , A61P27/02 , A61K9/0019 , C07K2317/51 , C07K2317/515 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/94 , A61K2039/505
Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
-
Patent Agency Ranking
公开(公告)号：US11548951B1
公开(公告)日：2023-01-10
申请号：US17822978
申请日：2022-08-29
Applicant: Viridian Therapeutics, Inc.
Inventor： Vahe Bedian , Peter Harwin , Tomas Kiselak , Angela She , Jonathan Violin , Yang Zhao
Abstract: Antibodies and compositions against Insulin-Like Growth Factor-1 Receptor (IGF-1R) and uses thereof are provided herein and antibodies and pharmaceutical compositions that can be used in methods of treating or reducing the severity of thyroid eye disease (TED) in subjects in need thereof, including reducing proptosis and Clinical Activity Score (CAS) in said subjects, by inhibiting the activity of IGF-1R with such antibodies and compositions.
-
公开(公告)号：US20230002495A1
公开(公告)日：2023-01-05
申请号：US17822978
申请日：2022-08-29
Applicant: Viridian Therapeutics, Inc.
Inventor： Vahe Bedian , Peter Harwin , Tomas Kiselak , Angela She , Jonathan Violin , Yang Zhao
Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
-
公开(公告)号：US20220235137A1
公开(公告)日：2022-07-28
申请号：US17450872
申请日：2021-10-14
Applicant: Viridian Therapeutics, Inc.
Inventor： Vahe Bedian , Peter Harwin , Tomas Kiselak , Angela She , Jonathan Violin , Yang Zhao
Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
-
公开(公告)号：US20230084477A1
公开(公告)日：2023-03-16
申请号：US17818798
申请日：2022-08-10
Applicant: Viridian Therapeutics, Inc.
Inventor： Denis O'Shaughnessy , Barrett Katz
Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
-
公开(公告)号：US20220267451A1
公开(公告)日：2022-08-25
申请号：US17501430
申请日：2021-10-14
Applicant: Viridian Therapeutics, Inc.
Inventor： Vahe Bedian , Peter Harwin , Tomas Kiselak , Angela She , Jonathan Violin , Yang Zhao
Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
-
-
-
-
-
-
-
-
-
Search Results
14
records
(took 0.022 seconds)
